Association of BP with death, cardiovascular events, and progression to chronic dialysis in patients with advanced kidney disease

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 6, 2015, Pages 934-940

  Palit, Shyamal ^a   Chonchol, Michel ^a   Cheung, Alfred K ^b,c   Kaufman, James ^d   Smits, Gerard ^a   Kendrick, Jessica ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF UTAH   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Blood pressure; Cardiovascular disease; Chronic kidney disease

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE; ANTIHYPERTENSIVE AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CREATININE CLEARANCE; DEATH; DIALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE COURSE; DOUBLE BLIND PROCEDURE; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; HUMAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PREVALENCE; PULSE PRESSURE; RANDOMIZED CONTROLLED TRIAL; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME; ADVERSE EFFECTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DRUG EFFECTS; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; KIDNEY; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RENAL INSUFFICIENCY, CHRONIC; RISK FACTOR; TIME FACTOR; UNITED STATES;

AGED; ANTIHYPERTENSIVE AGENTS; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; DOUBLE-BLIND METHOD; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84930457788     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.08620814     Document Type: Article

References (26)

1. Wright JT Jr, Bakris G, Greene T, Agodoa LY, Appel LJ, Charleston J, Cheek D, Douglas-Baltimore JG, Gassman J, Glassock R, Hebert L, Jamerson K, Lewis J, Phillips RA, Toto RD,Middleton JP, Rostand SG; African American Study of Kidney Disease and Hypertension StudyGroup: Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial. JAMA 288: 2421-2431, 2002
2. Ruggenenti P, Perna A, Loriga G, Ganeva M, Ene-Iordache B, Turturro M, Lesti M, Perticucci E, Chakarski IN, Leonardis D, Garini G, Sessa A, Basile C, Alpa M, Scanziani R, Sorba G, Zoccali C, Remuzzi G; REIN-2 Study Group: Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial. Lancet 365: 939-946, 2005
3. Kovesdy CP, Bleyer AJ, Molnar MZ, Ma JZ, Sim JJ, Cushman WC, Quarles LD, Kalantar-Zadeh K: Blood pressure and mortality in U.S. veterans with chronic kidney disease: A cohort study. Ann Intern Med 159: 233-242, 2013
4. Weiner DE, Tighiouart H, Levey AS, Elsayed E, Griffith JL, Salem DN, Sarnak MJ: Lowest systolic blood pressure is associated with stroke in stages 3 to 4 chronic kidney disease. J Am Soc Nephrol 18: 960-966, 2007
5. Toussaint ND, Lau KK, Strauss BJ, Polkinghorne KR, Kerr PG: Associations between vascular calcification, arterial stiffness and bone mineral density in chronic kidney disease. Nephrol Dial Transplant 23: 586-593, 2008
6. Peralta CA, Shlipak MG, Wassel-Fyr C, Bosworth H, Hoffman B, Martins S, Oddone E, Goldstein MK: Association of antihypertensive therapy and diastolic hypotension in chronic kidney disease. Hypertension 50: 474-480, 2007
7. Blacher J, Staessen JA, Girerd X, Gasowski J, Thijs L, Liu L,Wang JG, Fagard RH, Safar ME: Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med 160: 1085-1089, 2000
8. Millar JA, Lever AF, Burke V: Pulse pressure as a risk factor for cardiovascular events in the MRC Mild Hypertension Trial. J Hypertens 17: 1065-1072, 1999
9. Klassen PS, Lowrie EG, Reddan DN, DeLong ER, Coladonato JA, Szczech LA, Lazarus JM,OwenWFJr: Association between pulse pressure and mortality in patients undergoing maintenance hemodialysis. JAMA 287: 1548-1555, 2002
10. Banerjee D, Brincat S, Gregson H, Contreras G, Streather C, Oliveira D, Nelson S: Pulse pressure and inhibition of reninangiotensin system in chronic kidney disease. Nephrol Dial Transplant 21: 975-978, 2006
11. Arulkumaran N, Diwakar R, Tahir Z, Mohamed M, Kaski JC, Banerjee D: Pulse pressure and progression of chronic kidney disease. J Nephrol 23: 189-193, 2010
12. Bakris GL, Weir MR, Shanifar S, Zhang Z, Douglas J, van Dijk DJ, Brenner BM; RENAAL Study Group: Effects of blood pressure level on progression of diabetic nephropathy: Results from the RENAAL study. Arch Intern Med 163: 1555-1565, 2003
13. Jamison RL, Hartigan P, Kaufman JS, Goldfarb DS, Warren SR, Guarino PD, Gaziano JM; Veterans Affairs Site Investigators: Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: A randomized controlled trial. JAMA 298: 1163-1170, 2007
14. Iseki K, Miyasato F, Tokuyama K, Nishime K, Uehara H, Shiohira Y, Sunagawa H, Yoshihara K, Yoshi S, Toma S, Kowatari T,Wake T, Oura T, Fukiyama K: Low diastolic blood pressure, hypoalbuminemia, and risk of death in a cohort of chronic hemodialysis patients. Kidney Int 51: 1212-1217, 1997
15. Weiss JW, Johnson ES, Petrik A, Smith DH, Yang X, Thorp ML: Systolic blood pressure and mortality among older communitydwelling adults with CKD. Am J Kidney Dis 56: 1062-1071, 2010
16. Duranti E, Imperiali P, SasdelliM: Is hypertension a mortality risk factor in dialysis? Kidney Int Suppl 55: S173-S174, 1996
17. Fleischmann EH, Bower JD, Salahudeen AK: Risk factor paradox in hemodialysis: Better nutrition as a partial explanation. ASAIO J 47: 74-81, 2001
18. Port FK, Hulbert-Shearon TE, Wolfe RA, Bloembergen WE, Golper TA, Agodoa LY, Young EW: Predialysis blood pressure and mortality risk in a national sample of maintenance hemodialysis patients. Am J Kidney Dis 33: 507-517, 1999
19. Zager PG, Nikolic J, Brown RH, Campbell MA, Hunt WC, Peterson D, Van Stone J, Levey A, Meyer KB, Klag MJ, Johnson HK, Clark E, Sadler JH, Teredesal P: "U" curve association of blood pressure and mortality in hemodialysis patients. Medical Directors of Dialysis Clinic, Inc. Kidney Int 54: 561-569, 1998
20. WinstonGJ, PalmasW, Lima J, Polak JF, Bertoni AG, Burke G, Eng J, Gottesman R, Shea S: Pulse pressure and subclinical cardiovascular disease in the multi-ethnic study of atherosclerosis.AmJ Hypertens 26: 636-642, 2013
21. O'Rourke M, Frohlich ED: Pulse pressure: Is this a clinically useful risk factor? Hypertension 34: 372-374, 1999
22. Hunsicker LG, Adler S, Caggiula A, England BK, Greene T, Kusek JW, Rogers NL, Teschan PE: Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int 51: 1908-1919, 1997
23. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Ford CE, Shulman NB, Stamler J: Blood pressure and end-stage renal disease in men. N Engl J Med 334: 13-18, 1996
24. Locatelli F, Marcelli D, Comelli M, Alberti D, Graziani G, Buccianti G, Redaelli B, Giangrande A; Northern Italian Cooperative Study Group: Proteinuria and blood pressure as causal components of progression to end-stage renal failure. Nephrol Dial Transplant 11: 461-467, 1996
25. McIntyre NJ, Fluck RJ, McIntyre CW, Fakis A, Taal MW: Determinants of arterial stiffness in chronic kidney disease stage 3. PLoS ONE 8: e55444, 2013
26. Kim CS, Kim HY, Kang YU, Choi JS, Bae EH, Ma SK, Kim SW: Association of pulse wave velocity and pulse pressure with decline in kidney function. J Clin Hypertens (Greenwich) 16: 372- 377, 2014